Table 1.
Patient characteristics
| Number (%) | 344 (100) |
| Age (SD) | 58 (16.4) |
| Male sex (%) | 236 (68.6) |
| SOFA score before transport (SD/range) | 8.8 (4.1/0–20) |
| Need for higher level ICU or advanced therapy (%) | 218 (63.4) |
| Median days of hospital admission before transport (range) | 4 (0–244) |
| P/F ratio (SD) | 246 (113) |
| Use of continuous vasoactive medication (%) | 152 (44.2) |
| pH at time of request for transport (SD) | 7.37 (0.1) |
| Additional medical devices (%) | 22 (6.4) |
| Invasive mechanical ventilation (%) | 311 (90.4) |
| Non-invasive mechanical ventilation (%) | 6 (1.7) |
| V-V ECMO | V-A ECMO | All ECMO patients | |
|---|---|---|---|
| Number | 7 | 8 | 15 |
| Age (SD) | 40 (15.9) | 52 (8.6) | 46 (13.4) |
| Male sex (%) | 5 (71.4) | 7 (87.5) | 12 (80.0) |
| SOFA score before transport (SD/range) | 14.0 (1.5/13–17) | 13.8 (2.4/11–17) | 13.9 (2.0/11–17) |
| Days of hospital admission before transport (median/range) | 3 (0–27) | 4 (2–10) | 4 (0–27) |
| P/F ratio (SD) | 92 (41) | 240 (87) | 177 (106) |
| Use of continuous vasoactive medication (%) | 6 (85.7) | 6 (75.0) | 12 (80.0) |
| pH at time of request for transport (median/SD) | 7.28 (0.1) | 7.45 (0.1) | 7.37 (0.12) |
Vasoactive medication: norepinephrine, dobutamine, nitroglycerine.
Additional medical devices: V-V and V-A ECMO, IABP, NO.
Short-term cardiac assist devices: V-A ECMO or IABP.
ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic balloon counter pulsation; NO, nitric oxide; P/F, PaO2/FiO2 ratio; SOFA, Sequential Organ Failure Assessment; V-A ECMO, veno-arterial ECMO; V-V ECMO, veno-venous ECMO.